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Many isolates of glucose-nonfermenting gram-negative bacilli (NFB) cultured
from clinical veterinary specimens are not identified because of the large number
of identification tests required. We evaluated two commercial identification
systems to determine if they could accurately identify NFB isolated from animals.
Of 182 strains of NFB, the MicroScan Urinary Combo Panel (MicroScan, Inc.,
Campbell, Calif.) correctly identified 72%, and the API 20E system (Analytab
Products, Plainview, N.Y.) correctly identified 74%. Of the 118 strains of the
three most common species of NFB isolated from animals, the MicroScan
Urinary Combo Panel identified 86% correctly, and the API 20E system identified
92% correctly. The use of either of these systems could improve the accuracy of
identification of NFB from clinical veterinary materials.
Glucose-nonfermenting gram-negative bacilli
(NFB) isolated from clinical veterinary speci-
mens often are not completely identified be-
cause of the large number of identification tests
required. Since many NFB have not been identi-
fied, little is known about their role in animal
diseases. We recently found that almost 10% of
all clinical veterinary specimens submitted for
culturing yielded NFB isolates (5). The complete
identification of NFB isolated from animals
would yield valuable information about the clini-
cal role of these organisms.
Commercial identification systems would be
very useful in identifying NFB if they could
accurately identify strains of animal origin. The
data bases of these systems are based mostly on
human strains, and differences between biotypes
of human and veterinary isolates of NFB may
exist. The purpose of this study was to deter-
mine the accuracy of two commercial systems,
the MicroScan Urinary Combo Panel (MS) (Mi-
croScan, Inc., Campbell, Calif.) and the API
20E system (API) (Analytab Products, Plain-
view, N.Y.), in the identification of NFB isolat-
ed from clinical veterinary materials.
MATERIALS AND METHODS
Bacterial strains. Nonfermenting strains used were
identified by conventional methods described else-
where (5). Identifications made by conventional meth-
ods were considered correct for purposes of compari-
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son. A total of 182 strains of NFB, representing 26
species, were tested with each system. Clinical veteri-
nary isolates accounted for 160 strains, and 22 strains
of human origin (provided by G. L. Gilardi, Hospital
for Joint Diseases, New York, N.Y.) were also tested.
Each isolate was streaked onto a blood agar plate and
then incubated for 18 to 24 h. The growth was checked
for purity and served as the source of the inoculum for
both systems.
MS. The MS contains a set of 24 miniaturized
identification tests combined with a minimum inhibi-
tory concentration system for several antimicrobial
agents in a microtiter plate. The MS comes frozen and
is thawed just before inoculation. The MS was inocu-
lated, incubated, and interpreted according to the
manufacturer's instructions.
The MS was inoculated with approximately 105
colony-forming units per well and then incubated
aerobically at 35°C. Positive reactions were recorded
at 24 h. At 48 h, reagents were added to tests requiring
them, and all tests were interpreted. The tests and
substrates used in the MS to identify NFB are urease
production, indole production, H2S production, lysine
and ornithine decarboxylase, arginine dihydrolase,
tryptophan deaminase, Voges-Proskauer, esculin hy-
drolysis, utilization of citrate, acetamide, malonate,
and tartrate, cetrimide tolerance, o-nitrophenyl-P-D-
galactopyranoside, glucose (oxidation-fermentation),
nitrate reduction, starch hydrolysis, susceptibility to
penicillin (4 ,ug/ml), kanamycin (4 ,ug/ml), colistin (4
FLg/ml), nitrofurantoin (64 ,ug/ml), and tobramycin (4
,ug/ml), and oxidase. Positive tests were used to code a
profile number for each isolate. This profile number,
as listed in the MicroScan data base, determined the
identity of the isolate.
API. The API consists of a plastic strip containing 20
tubules that accommodate 21 identification tests. For











TABLE 1. Accuracy of the MS in identifying NFB from animals
No. (%) of strains that were
Organism (no. of strains tested) Correctly Within a Incorrectly Not
identified spectrum of identified identified
identification
Pseudomonas aeruginosa (50) 44 (88) 0 (0) 3 (6) 3 (6)
P. fluorescens (3) 1 (33) 1 (33) 1 (33) 0 (0)
P. putida (5) 3 (60) 1 (20) 1 (20) 0 (0)
Acinetobacter calcoaceticus biotype anitratus (25) 25 (100) 0 (0) 0 (0) 0 (0)
A. calcoaceticus biotype Iwoffii (25) 19 (76) 0 (0) 1 (4) 5 (20)
Bordetella bronchiseptica (18) 13 (72) 0 (0) 5 (28) 0 (0)
Pseudomonas pseudoalcaligenes (8) 1 (13) 6 (75) 1 (13) 0 (0)
P. maltophilia (5) 3 (60) 0 (0) 0 (0) 2 (40)
P. stutzeri (6) 4 (67) 1 (17) 1 (17) 0 (0)
P. alcaligenes (5) 2 (40) 0 (0) 3 (60) 0 (0)
Moraxella phenylpyruvica (4) 0 (0) 0 (0) 4 (100) 0 (0)
CDC M-5 (3) 3 (100) 0 (0) 0 (0) 0 (0)
Moraxella nonliquefaciens (1) 1 (100) 0 (0) 0 (0) 0 (0)
M. osloensis (1) 1 (100) 0 (0) 0 (0) 0 (0)
Pseudomonas putrefaciens (1) 1 (100) 0 (0) 0 (0) 0 (0)
Alcaligenes faecalis (3) 1 (33) 1 (33) 1 (33) 0 (0)
A. odorans (2) 2 (100) 0 (0) 0 (0) 0 (0)
CDC IIf (3) 2 (67) 0 (0) 0 (0) 1 (33)
Flavobacterium meningosepticum (1) 1(100) 0 (0) 0 (0) 0 (0)
CDC Ve-2 (3) 1 (33) 0 (0) 1 (33) 1 (33)
Pseudomonas testosteroni (2) 0 (0) 0 (0) 2 (100) 0 (0)
CDC Ve-1 (1) 0 (0) 0 (0) 1 (100) 0 (0)
CDC Va-1 (1) 0 (0) 0 (0) 1 (100) 0 (0)
Pseudomonas cepacia (1) 1 (100) 0 (0) 0 (0) 0 (0)
Achromobacter xylosoxidans (1) 1 (100) 0 (0) 0 (0) 0 (0)
Pseudomonas acidovorans (1) 1 (100) 0 (0) 0 (0) 0 (0)
P. diminuta (3) 0 (0) 0 (0) 3 (100) 0 (0)
Total (182) 131 (72) 10 (5) 29 (16) 12 (7)
tion-fermentation), oxidase, motility, and growth on
MacConkey medium, were performed and used to
code a profile number. The API (including the addi-
tional tests) was inoculated, incubated, and interpret-
ed according to the manufacturer's instructions.
The API (including the additional tests) was incubat-
ed aerobically at 35°C. Positive tests were recorded at
24 h of incubation. Necessary reagents were added at
48 h, and all tests were interpreted then. The tests and
substrates used in the API to identify NFB are o-
nitrophenyl-o-D-galactopyranoside, arginine dihydro-
lase, lysine and ornithine decarboxylase, utilization of
citrate, H2S production, urease production, trypto-
phan deaminase, indole production, Voges-Proskauer,
gelatin liquefaction, oxidation of glucose, mannitol,
inositol, sorbitol, rhamnose, sucrose, melibiose,
amygdalin, and arabinose, oxidase, nitrate reduction,
glucose (oxidation-fermentation), motility, and growth
on MacConkey medium. Positive tests were used to
code a profile number for each isolate. This profile
number, as listed in the Analytab Products data base,
determined the identity of the isolate.
Interpretation of the identifications. The identity of
an isolate determined by each system was compared
with that determined by conventional methods. The
identifications were classified into four categories: (i)
correct; (ii) one of a spectrum of identifications, but
not the first choice; (iii) incorrect; and (iv) no identifi-
cation listed.
An identification was considered to be correct if the
same species as identified by conventional methods
was listed as the first choice in the data base. For the
MS, the identification was also considered correct if it
was listed as a part of the spectrum of identifications
but could be separated from the other identifications
listed by additional characteristics given in the data
base. The only additional characteristics considered
were motility, colony morphology, and those for any
test that could be determined directly from the MS.
Since the API required tests in addition to those on
each strip to determine a profile number, no other tests
were done to confirm the identity of an isolate even
when additional tests were suggested in the profile
index.
The spectrum of identifications category was used
when the correct species identification was listed but
was not the first choice. This category was also used
when the correct genus identification was given but
when no species were listed. An isolate was consid-
ered incorrectly identified if it was wrongly identified
and was not given as an alternative choice. The no
identification listed category was used when the pro-
file number of the isolate did not appear in the data
base of the system.
RESULTS
The results of MS testing are shown in Table
1. This system correctly identified 72% of the
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TABLE 2. Accuracy of the API in identifying NFB from animals
No. (%) of strains that were
Organism (no. of strains tested) Correctly Within a Incorrectly Not
identified pidentfication identified identified
Pseudomonas aeruginosa (50) 45 (90) 0 (0) 0 (0) 5 (10)
P. fluorescens (3) 0 (0) 3 (100) 0 (0) 0 (0)
P. putida (5) 1 (20) 4 (80) 0 (0) 0 (0)
Acinetobacter calcoaceticus biotype anitratus (25) 20 (80) 0 (0) 0 (0) 5 (20)
A. calcoaceticus biotype Iwoffii (25) 25 (100) 0 (0) 0 (0) 0 (0)
Bordetella bronchiseptica (18) 18 (100) 0 (0) 0 (0) 0 (0)
Pseudomonas pseudoalcaligenes (8) 0 (0) 8 (100) 0 (0) 0 (0)
P. maltophilia (5) 5 (100) 0 (0) 0 (0) 0 (0)
P. stutzeri (6) 4 (67) 1 (17) 1 (17) 0 (0)
P. alcaligenes (5) 0 (0) 5 (100) 0 (0) 0 (0)
Moraxella phenylpyruvica (4) 0 (0) 0 (0) 4 (100) 0 (0)
CDC M-5 (3) 2 (67) 1 (33) 0 (0) 0 (0)
Moraxella nonliquefaciens (1) 0 (0) 0 (0) 0 (0) 1 (100)
M. osloensis (1) 1(100) 0 (0) 0 (0) 0 (0)
Pseudomonas putrefaciens (1) 1 (100) 0 (0) 0 (0) 0 (0)
Alcaligenes faecalis (3) 3 (100) 0 (0) 0 (0) 0 (0)
A. odorans (2) 1 (50) 1 (50) 0 (0) 0 (0)
CDC Ilf (3) 2 (67) 1 (33) 0 (0) 0 (0)
Flavobacterium meningosepticum (1) 1 (100) 0 (0) 0 (0) 0 (0)
CDC Ve-2 (3) 2 (67) 1 (33) 0 (0) 0 (0)
Pseudomonas testosteroni (2) 0 (0) 2 (100) 0 (0) 0 (0)
CDC Ve-1 (1) 1 (100) 0 (0) 0 (0) 0 (0)
CDC Va-i (1) 0 (0) 0 (0) 1 (100) 0 (0)
Pseudomonas cepacia (1) 1 (100) 0 (0) 0 (0) 0 (0)
Achromobacter xylosoxidans (1) 1 (100) 0 (0) 0 (0) 0 (0)
Pseudomonas acidovorans (1) 0 (0) 1 (100) 0 (0) 0 (0)
P. diminuta (3) 0 (0) 2 (67) 0 (0) 1 (33)
Total (182) 134 (74) 30 (16) 6 (3) 12 (7)
182 nonfermenting strains. It misidentified 16%
of these isolates and did not identify 7% of the
NFB. This system correctly identified 86% of
the most common NFB, Pseudomonas aerugi-
nosa, Acinetobacter calcoaceticus, and Borde-
tella bronchiseptica. It had the most difficulty
identifying the inert species of NFB.
The API correctly identified 74% of the 182
strains (Table 2). It misidentified 3% of these
isolates and did not identify 7% of the NFB. This
system correctly identified 92% of the three
most common NFB (see above). It had the most
difficulty identifying the inert species of NFB
and the fluorescent pseudomonads other than P.
aeruginosa.
DISCUSSION
Since it is a new product, there are no report-
ed evaluations of the MS for identification of
human or veterinary NFB. It correctly identified
72% of the 182 strains. This is higher accuracy
than our diagnostic laboratory obtained with a
small number of conventional identification
tests.
The API has been extensively evaluated for
identification of NFB from humans (1, 4, 6-10).
This system has been reported to identify 64% of
animal strains of Pasteurella multocida and 20%
of animal strains of Pasteurella haemolytica (3).
Collins and Swanson reported that the API
identified 62% of non-Enterobacteriaceae
strains, including some nonfermenting strains
from animals (2). In this study, 74% of 182
isolates were correctly identified.
The NFB most commonly isolated from ani-
mals are P. aeruginosa, A. calcoaceticus, and B.
bronchiseptica (5). These three organisms make
up 86% of the nonfermenters cultured from
clinical veterinary specimens. Of 118 strains of
the three most common NFB, the API identified
92%, and the MS identified 86%. Both systems
tested would be accurate enough for routine
identification of NFB isolated from clinical vet-
erinary materials.
The purpose of this study was to determine if
these commercial systems could accurately
identify NFB isolated from animals. At present
the identification of most NFB in clinical veteri-
nary laboratories is incomplete. The use of ei-
ther system could improve the accuracy of iden-
tification of NFB in clinical veterinary
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isolates would help to clarify the role of NFB in
animal diseases.
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